<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04062071</url>
  </required_header>
  <id_info>
    <org_study_id>version1 last update 30/7/2019</org_study_id>
    <nct_id>NCT04062071</nct_id>
  </id_info>
  <brief_title>Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients</brief_title>
  <official_title>Prevalence of Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal in Non-valvular Atrial Fibrillation Patients---- A Study in Hong Kong General Out-patient Clinic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prince of Wales Hospital, Shatin, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Prince of Wales Hospital, Shatin, Hong Kong</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation is a clinically significant cardiac arrhythmia that increases the risk of
      stroke by 3 to 4 times. Oral anticoagulation has been shown to mitigate stroke risk by
      two-thirds among patients with AF and is widely recommended in optimizing AF
      management.Direct oral anticoagulants have also been demonstrated to be superior to warfarin
      with respect to the risk of fatal bleeding and stroke prevention.

      However, the previous study finding highlighted a great gap between current guidelines and
      the clinical management of AF .Nonetheless, the decision for anticoagulant use is not
      straightforward.It is worth to investigate the updated prevalence of anticoagulant use, the
      reasons for not receiving anticoagulant, and the factors independently associated with
      anticoagulant refusal in patients with non-valvular atrial fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 23, 2019</start_date>
  <completion_date type="Anticipated">March 23, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 23, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>The prevalence of anticoagulant use in non-valvular atrial fibrillation patients</measure>
    <time_frame>August 2019 to March 2020</time_frame>
    <description>calculate the prevalence of anticoagulant use in non-valvular atrial fibrillation patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the rate of the refusal of anticoagulant use</measure>
    <time_frame>August 2019 to March 2020</time_frame>
    <description>calculate the rate of refusal of anticoagulant use in the eligible non-valvular atrial fibrillation patients</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all of the documented atrial fibrillation patients having regular follow up in GOPC in the
        study period
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis as atrial fibrillation

          -  aged â‰§18 years

          -  able to given consent

        Exclusion Criteria:

          -  Unable/unwillingness to sign informed consent to study

          -  mechanical heart valve

          -  moderate-to-severe mitral stenosis

          -  Transient atrial fibrillation from reversible cause (e.g., during respiratory tract
             infection or bronchospasm)

          -  pregnancy

          -  hospitalization within 1 month prior to inclusion in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>LIAO, Jiawei</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <contact>
      <last_name>LIAO Jiawei</last_name>
      <phone>51718217</phone>
      <email>mirachen2002@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 16, 2019</study_first_submitted>
  <study_first_submitted_qc>August 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Prince of Wales Hospital, Shatin, Hong Kong</investigator_affiliation>
    <investigator_full_name>chen liujing</investigator_full_name>
    <investigator_title>resident</investigator_title>
  </responsible_party>
  <keyword>anticoagulants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no Conflict of interest</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

